Using Exenatide Twice Daily or Insulin in Clinical Practice: Results from CHOICE

INTRODUCTION: CHOICE (CHanges to treatment and Outcomes in patients with type 2 diabetes initiating InjeCtablE therapy; NCT00635492) assessed, as its primary objective, the time to a ‘significant treatment change’ (defined within this paper) after patients with type 2 diabetes mellitus initiated the...

Descripción completa

Detalles Bibliográficos
Autores principales: Mathieu, Chantal, Östenson, Claes-Göran, Matthaei, Stephan, Reaney, Matthew, Krarup, Thure, Guerci, Bruno, Kiljański, Jacek, Salaun-Martin, Carole, Sapin, Hélène, Theodorakis, Michael
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2013
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3889314/
https://www.ncbi.nlm.nih.gov/pubmed/24018835
http://dx.doi.org/10.1007/s13300-013-0037-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3889314/
https://www.ncbi.nlm.nih.gov/pubmed/24018835
http://dx.doi.org/10.1007/s13300-013-0037-8

Ejemplares similares